This inventor holds 78 USPTO granted patents and 23 published patent applications and 4 EPO patents, primarily in Antibody Engineering (CPC class 4352). Top assignees: Genentech, Inc., Genencor International, Inc., University of California. Active years: 1988-2026.
Inventors with similar research interests:
Location History:
- Burningame, CA (US) (1998)
- San Mateo, CA (US) (1988 - 1999)
- Auburn, NY (US) (2002)
- Tallahassee, FL (US) (2008)
- South San Francisco, CA (US) (2009)
- Burlingame, CA (US) (1994 - 2021)
- San Francisco, CA (US) (2023 - 2024)
Company Filing History:
49 out of 3,288 
10 out of 422 
10 out of 15,964 
Years Active: 1988-2026
Areas of Expertise:
Title: The Inventor Extraordinaire: James A Wells
Introduction:
James A Wells, a prolific inventor hailing from Burlingame, CA, has made significant contributions to the field of biotechnology. With an impressive portfolio of 77 patents under his belt, Wells is a trailblazer in the realm of antibody research and its applications in cancer treatment and detection.
Latest Patents:
Among his latest patents is the groundbreaking work on antibodies against CDCP1 for the treatment and detection of cancer. This innovative approach targets the CUB domain-containing protein 1 (CDCP1) with specific antibodies and antibody fragments, offering promising new avenues for combating various forms of cancer. Additionally, Wells has delved into the development of engineered antibodies for the detection of phosphorylated tyrosine, unveiling novel compositions that enhance the detection of phosphotyrosine-bearing proteins.
Career Highlights:
Wells' illustrious career has seen him making significant strides at renowned companies such as Genentech, Inc. and Genencor International, Inc. His expertise and groundbreaking research have garnered recognition within the biotech industry, solidifying his reputation as a pioneering inventor in the field of biotechnology.
Collaborations:
Throughout his career, Wells has collaborated with esteemed professionals in the industry, including notable coworkers Brian C Cunningham and Henry Bernard Lowman. These collaborations have led to the development of innovative solutions and have enhanced the collective knowledge base in the domain of antibody research and cancer detection.
Conclusion:
In conclusion, James A Wells stands as a beacon of innovation in the field of biotechnology, with a remarkable track record of patents and groundbreaking inventions. His dedication to advancing antibody research for cancer detection and treatment showcases his commitment to making a lasting impact on the field. Wells' collaborations with industry peers and his tenure at esteemed companies underscore his influence and contributions to the realm of biotechnology.